Creative Medical Technology Holdings, Inc. Discusses CaverStem and Other Patented Technology with The Stock Day Podcast (CELZ) October 17, 2019.

Newsfile Corp.Newsfile Corp

Phoenix, Arizona–(Newsfile Corp. – October 17, 2019) – The Stock Day Podcast welcomed Creative Medical Technology Holdings, Inc. (CELZ) (“the Company”), a commercial stage biotechnology company currently trading on the OTC. CEO of the Company, Timothy Warbington, joined Stock Day host Everett Jolly.

Jolly began the interview by asking about the Company’s origins. Warbington shared that the founders came together in 2011 with the acquisition of intellectual property from another biotechnology company of which they were all involved. In 2016 the CaverStem technology was spun out and Creative Medical Technology Holdings, Inc. was formed and taken public as a fully reporting company via a reverse merger.

Jolly then asked about the Company’s flagship technology, CaverStem, which is an erectile dysfunction treatment that uses the patient’s own stem cells to heal the body. Warbington explained that CaverStem is a unique product from a business perspective as it allows the Company to operate with a steady cash flow. Meanwhile, the technology also offers significant merit in the medical and science communities as a safe and effective alternative to commercial erectile dysfunction medications.

Jolly then asked about the treatment process of the CaverStem technology. Warbington shared that the treatment is a simple out-patient procedure that takes about thirty minutes to complete. Warbington also shared the simple monetization strategy that the Company follows for the CaverStem technology. “The revenue that is generated by our company is from the sale of medical equipment. There is a device that is required for each patient treated,” said Warbington.

“The kit is patented,” shared Warbington, adding that the Company also has worldwide exclusive distribution rights for the urology space and has an excellent relationship with their supplier, as well as IT protection.

Jolly then asked about the Company’s partnership with Edge Media Network. Warbington explained that the Company is preparing for a variety of marketing campaigns in the near future, and Edge Media Network represents a beneficial partnership for this task.

Jolly then asked about the Company’s long-term visions and potential. Warbington shared that the Company is optimistic for the future and will focus on continuing to train physicians and treats patients. “We have a number of different patents within our portfolio that are continuing to be prosecuted and pushed along to maturity,” said Warbington, adding that the Company also offers an additional product called FemCelz, which treats sexual dysfunction in females with the use of the patient’s stem cells. “We’re optimistic about FemCelz because it’s the counterpart to CaverStem for men.”

Warbington also expanded on the Company’s StemSpine product, which is another patented technology in their portfolio and will be available on the market in the near future.

To close the interview, Warbington encouraged listeners to consider the value of the Company’s medical technology and patents. “This is serious medicine regarding sexual dysfunction. We’re trying to increase shareholder value,” said Warbington. He also shared that the Company is looking forward to the exciting news that will be coming out regarding their other products in the near future. “We’re very optimistic and we think we have a very bright future,” closed Warbington.

To hear Timothy Warbington’s entire interview, follow the link to the podcast here:

Investors Hangout is a proud sponsor of “Stock Day,” and Stock Day Media encourages listeners to visit the company’s message board at https://investorshangout.com/

About Creative Medical Technology Holdings, Inc.

Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company currently trading on the OTC under the ticker symbol CELZ. For further information about the company go to www.creativemedicaltechnology.com. For more information on our Caverstem® procedure please go to www.caverstem.com.

Forward-Looking Statements

OTC Markets has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. This news release may contain forward-looking statements including but not limited to comments regarding the timing and content of upcoming clinical trials and laboratory results, marketing efforts, funding, etc. Forward-looking statements address future events and conditions and, therefore, involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements. See the periodic and other reports filed by Creative Medical Technology Holdings, Inc. with the Securities and Exchange Commission and available on the Commission’s website at www.sec.gov.

Contact Information:

Email: CEO@CreativeMedicalHealth.com

About The “Stock Day” Podcast

Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America. Stock Day recently launched its Video Interview Studio located in Phoenix, Arizona.

SOURCE:
Stock Day Media
602-441-3474

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/48869

https://www.newsfilecorp.com/newsinfo/48869/131
Creative Medical Technology Holdings, Inc. Logo